Center for Scientific Review; Amended Notice of Meeting, 31508 [2021-12413]

Download as PDF 31508 Federal Register / Vol. 86, No. 112 / Monday, June 14, 2021 / Notices HRSA, an operating division of HHS, is publishing a list of individuals who may be named to serve on the Senior Executive Service Performance Review Board that oversees the evaluation of performance appraisals for Senior Executive Service members for the Fiscal Years 2021 and 2022. FOR FURTHER INFORMATION CONTACT: Georgia Lyons, HRSA Executive Resources, Office of Human Resources, 5600 Fishers Lane, Rm 12N06C, Rockville, Maryland 20857, or (301) 443–4618. SUPPLEMENTARY INFORMATION: Title 5, U.S.C. Section 4314(c)(4) of the Civil Service Reform Act of 1978, Public Law 95–454, requires that the appointment of Performance Review Board Members be published in the Federal Register. The following individuals may be named to serve on the Senior Executive Service Performance Review Board: Onyekachukwu Anaedozie Anthony Archeval Leslie Atkinson Cynthia Baugh Tonya Bowers Adriane Burton Tina Cheatham Laura Cheever Natasha Coulouris Cheryl Dammons Elizabeth DeVoss Diana Espinosa Catherine Ganey Alexandra Garcia Jordan Grossman Heather Hauck Danita Hunter Laura Kavanagh Martin Kramer Torey Mack James Macrae Susan Monarez Thomas Morris Luis Padilla Krista Pedley Wendy Ponton Ashley Rose Tracey Trautman Michael Warren SUMMARY: Diana Espinosa, Acting Administrator. [FR Doc. 2021–12366 Filed 6–11–21; 8:45 am] Dated: June 9, 2021. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–12413 Filed 6–11–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director; Notice of Charter Renewal In accordance with Title 42 of the U.S. Code of Federal Regulations, Section 217a, notice is hereby given that the Charter for the Advisory Committee to the Director, National Institutes of Health was renewed for an additional two-year period on May 31, 2021. It is determined that the Advisory Committee to the Director, National Institutes of Health is in the public interest in connection with the performance of duties imposed on the National Institutes of Health by law, and that these duties can best be performed through the advice and counsel of this group. Inquiries may be directed to Claire Harris, Director, Office of Federal Advisory Committee Policy, Office of the Director, National Institutes of Health, 6701 Democracy Boulevard, Suite 1000, Bethesda, Maryland 20892 (Mail Stop Code 4875), Telephone (301) 496–2123, or harriscl@mail.nih.gov. Dated: June 8, 2021. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES lotter on DSK11XQN23PROD with NOTICES1 Neuroscience, Vision and Low Vision Technologies Study Section, June 16, 2021, 8:00 a.m. to June 17, 2021, 07:00 p.m., National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD, 20892 which was published in the Federal Register on June 08, 2021, 86 FR 30466. This notice is being amended to change the meeting start time from 8:00 a.m. to 10:00 a.m. The meeting is closed to the public. [FR Doc. 2021–12380 Filed 6–11–21; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel; Career Development (K), Conference Support (R13), and Research Education (R25) Review. Date: July 16, 2021. Time: 09:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications and/or proposals. Place: National Institutes of Health, Democracy II, 6707 Democracy Blvd., Bethesda, MD 20892 (Virtual Meeting). Contact Person: John K. Holden, Ph.D., Scientific Review Officer, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, 6707 Democracy Blvd., Suite 920, Bethesda, MD 20892, (301) 496–8775, john.holden@ mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, HHS) Dated: June 9, 2021. David W Freeman, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–12414 Filed 6–11–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health BILLING CODE 4140–01–P Center For Scientific Review; Notice of Closed Meetings National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. Notice is hereby given of a change in the meeting of the Bioengineering of VerDate Sep<11>2014 17:26 Jun 11, 2021 Jkt 253001 PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 E:\FR\FM\14JNN1.SGM 14JNN1

Agencies

[Federal Register Volume 86, Number 112 (Monday, June 14, 2021)]
[Notices]
[Page 31508]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-12413]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the 
Bioengineering of Neuroscience, Vision and Low Vision Technologies 
Study Section, June 16, 2021, 8:00 a.m. to June 17, 2021, 07:00 p.m., 
National Institutes of Health, Rockledge II, 6701 Rockledge Drive, 
Bethesda, MD, 20892 which was published in the Federal Register on June 
08, 2021, 86 FR 30466.
    This notice is being amended to change the meeting start time from 
8:00 a.m. to 10:00 a.m. The meeting is closed to the public.

    Dated: June 9, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-12413 Filed 6-11-21; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.